(NASDAQ: DWTX) Dogwood Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.97%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.15%.
Dogwood Therapeutics's earnings in 2026 is -$35,514,032.On average, 5 Wall Street analysts forecast DWTX's earnings for 2026 to be -$145,704,254, with the lowest DWTX earnings forecast at -$185,599,069, and the highest DWTX earnings forecast at -$80,314,034.
In 2027, DWTX is forecast to generate -$133,439,204 in earnings, with the lowest earnings forecast at -$145,664,173 and the highest earnings forecast at -$103,110,594.